Amplia teams up with big pharma for lung cancer trial
--------------------------------------------------------------------
Source: The Age
Published: 2026-08-04 12:23 UTC+10:00
Section: Business / Companies
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Australia, Law & Courts, Business & Economy, Crime & Justice
--------------------------------------------------------------------
Snippet:
Melbourne-based ASX listed biotech Amplia Therapeutics has secured a major collaboration with pharmaceutical goliath Eli Lilly & Company to evaluate a new combination therapy aimed at tackling non-small cell lung cancer (NSCLC).
--------------------------------------------------------------------